September 17, 2020
“Aquestive Therapeutics (AQST)… All in all, other analysts echo Moussatos’ sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $18.67, the upside potential comes in at 136%…… Continue Reading…
September 17, 2020
“Akero Therapeutics (AKRO)… Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target,… Continue Reading…
September 16, 2020
“… the New York Giants hosting the Pittsburgh Steelers attracted an average of 10.7 million viewers on Monday’ night the network announced, down 10.8% from last year’s first Monday night game. …The game peaked at 13.1 million viewers around 9:00 p.m.… Continue Reading…
September 16, 2020
“Southwest Airlines (LUV)… In line with his optimism, Shanker rates LUV an Overweight (i.e. Buy). His $54 price target implies a 33% upside for the stock in the coming year… Delta Airlines, Inc. (DAL)… Overall, the analyst consensus on Delta is a… Continue Reading…
September 16, 2020
“MediWound Ltd. (MDWD)… To this end, DeGeeter rates MDWD an Outperform along with a $7 price target. Should his thesis play out, a potential twelve-month gain of 117% could be in the cards… UroGen Pharma (URGN)… To this end, Gershell… Continue Reading…
September 15, 2020
“Venus Concept (VERO)… To this end, Thibault rates VERO a Buy along with a $7 price target. This target conveys the analyst’s confidence in VERO’s ability to climb 231% higher from current levels… Minerva Neurosciences (NERV)… What does the rest… Continue Reading…
September 15, 2020
“What are Treasurys doing? The 10-year Treasury note yield TMUBMUSD10Y, 0.681% rose 1.2 basis points to 0.681%, while the 2-year note rate TMUBMUSD02Y, 0.137% was steady at 0.139%. The 30-year bond yield TMUBMUSD30Y, 1.425% added 2.1 basis points to 1.429%. Bond prices move in the opposite direction of yields.… Continue Reading…
September 15, 2020
“Gilead Sciences will acquire biotech company Immunomedics in a $21 billion deal that will expand Gilead’s availability of cancer treatments, the companies announced on Sunday. Shares of Immunomedics surged more than 100% in premarket trading Monday. The deal will provide Gilead access to the drug Trodelvy, a… Continue Reading…
September 14, 2020
“Verizon Communications said Monday it would buy wireless services provider Tracfone, a unit of Mexican telecom America Movil, in a $6.25 billion cash and stock deal. Several mergers in recent years have led to an increasingly concentrated wireless industry in the U.S.,… Continue Reading…
September 14, 2020
“Chipmaker Nvidia has agreed to buy Arm Holdings, a designer of chips for mobile phones, from SoftBank in a deal worth $40 billion, the companies announced Sunday. The deal will include $21.5 billion in Nvidia stock and $12 billion in cash, including $2 billion payable at… Continue Reading…
Recent Comments